GW&K Investment Management, LLC

Position in KRYS — Krystal Biotech, Inc.

CIK 1082917 BOSTON, MA

Position in KRYS

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$6,799,702

+$1,828,334 QoQ

Shares Held

18,295

-4.9% QoQ

Ownership

0.062%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#93

of 422 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GW&K Investment Management, LLC holds $876,997,841 across 27 Biotechnology names. KRYS ranks #15 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	1,353,883	$105,968,422
2	JAZZ	Jazz Pharmaceuticals plc	350,667	$84,500,226
3	BBIO	BridgeBio Pharma, Inc.	1,125,131	$83,799,756
4	CYTK	Cytokinetics Inc	916,107	$78,043,155
5	LGND	Ligand Pharmaceuticals Inc	246,883	$78,037,246
6	VCEL	Vericel Corp	1,550,497	$68,981,610
7	INSM	INSMED Inc	629,760	$67,145,010
8	CRNX	Crinetics Pharmaceuticals, Inc.	1,731,140	$64,779,258

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,799,702	18,295	-4.9%	Shares	Sole	2026-08-12
2026-03-31	$4,971,368	19,245	-1.7%	Shares	Sole	2026-05-13
2025-12-31	$4,827,499	19,581	+86.6%	Shares	Sole	2026-02-11
2025-09-30	$1,852,152	10,492	-65.2%	Shares	Sole	2025-11-12
2025-06-30	$4,147,855	30,175	-11.5%	Shares	Sole	2025-08-11
2025-03-31	$6,148,230	34,100	-2.4%	Shares	Sole	2025-05-05
2024-12-31	$5,472,133	34,930	-3.1%	Shares	Sole	2025-02-05
2024-09-30	$6,558,358	36,029	-3.0%	Shares	Sole	2024-11-07
2024-06-30	$6,817,818	37,126	-1.1%	Shares	Sole	2024-08-12
2024-03-31	$6,677,357	37,528	—	Shares	Sole	2024-05-08
No filing history on record for this holder in this stock.